volved in embryogenesis and development [Ansari and Mandal, 2010] . Recently, de novo partial or complete deletions of the Xp11.23 located gene, lysine demethylase 6A (KDM6A) , have been identified as additional causes of KS, confirming the genetic heterogeneity of the disease [Lederer et al., 2012] , although these genetic events appear extremely rare in the pathogenesis of KS [Priolo et al., 2012] . KDM6A demethylates di-and trimethyl-lysine 27 on histone H3 maintaining embryonic stem cell pluripotency and plasticity during embryonic development and X chromosome inactivation [Hong et al., 2007] . KDM6A and MLL2 act together in the epigenetic control of transcriptionally active chromatin by counteracting polycomb-group (PcG) proteins that are involved in the tri-and dimethylation of H3K27 [Schuettengruber et al., 2007] .
Here we describe the first Moroccan KS patient with typical facial features characteristic for the syndrome, developmental delay and fetal fingertip pad. This patient carries a novel mutation in the MLL2 gene that results in abolishment of a splice donor site, leading to aberrant RNA isoform with consequent production of a truncated MLL2 protein.
Case Report
A 2-year-old boy was referred for medical genetics consultation because of the association of a dysmorphic facies and soft cleft palate. He is the firstborn of a healthy consanguineous couple (second degree), a 33-year-old mother and 38-year-old father, with no relevant familial history. The pregnancy was not medically followed, but it was reported without complications. At birth, he weighed 3,500 g; he had a length of 52 cm and 36 cm for head circumference. He presented neonatal hypotonia. His parents reported psychomotor and developmental delay and an increased susceptibility to infections with recurring upper respiratory tract infections during his 2 first years of life.
Clinical examination at 2 years of age showed a delay in growth development with a weight of 12 kg (25th centile), height of 81.5 cm (3rd-10th centile) and an OFC of 47.8 cm (25th centile), respectively. He presented with myopathic facies, long palpebral fissures, lower palpebral eversion, arched eyebrows, epicanthus, long eyelashes, depressed nasal tip, short nasal septum, micrognathia, and prominent and detached ears ( fig. 1 ) . He also had soft cleft palate scheduled for a surgical treatment, brachydactyly of hands and feet, short fifth fingers and finger pads. The urogenital examination showed a micropenis with a penile length of 3 cm (10th centile). He presented with developmental delay; he was still walking with support, and his speech was delayed. The clinical signs are summarized in table 1 . X-rays of the skull, cardiac and abdomino- genito-urinary ultrasonographies were normal (data not shown).
The results of laboratory examinations were within normal limits, and a chromosomal investigation revealed a normal male karyotype, 46,XY. On clinical examination, both the parents and their second sibling of 9 months were normal. Informed consent was obtained from the proband's parents prior to implementation of the molecular assay. Peripheral blood was collected from the affected child and his parents. Molecular genetic testing for suspected KS was performed by complete DNA sequence analysis of the entire coding region and flanking introns of the MLL2 gene, as reported previously [Micale et al., 2011] . This led to the identification of the de novo heterozygous donor splice site variant c.4693+1G>A in intron 17 ( fig. 2 ) . The variant was not found in the 1,000 genome database (http://www.1000genomes. org/) nor in the Exome Variant Server, suggesting that it is a rare event with potential pathological effect. The c.4693+1G>A splice site variant was evaluated for putative alteration of regulatory process at the transcriptional or splicing level with NetGene2 (http:// www.cbs.dtu.dk/services/NetGene2) and NNSPLICE (http:// www.fruitfly.org/seq_tools/splice.html). This variant was predict- ed to alter the splicing process by abolishing the donor splice site in the intron 17. RT-PCR and direct sequencing of amplified fragments from RNA prepared from the proband showed that the mutation activates a cryptic donor splice site in the exon 17, leading to a frameshift transcript with the generation of a truncated MLL2 protein ( fig. 2 ).
Discussion
KS is characterized by a typical dysmorphic appearance together with cognitive and growth delay, in addition to a variety of anomalies [Niikawa et al., 1981] .
To date, approximately 300 distinct MLL2 mutations have been characterized in patients with KS. The majority of MLL2 mutation-positive KS patients carry truncating mutations, including nonsense mutations, deletions, insertion of a single base, and small duplications. Splicesite, frameshift and missense mutations have also been described. The majority of them was de novo and predicted to cause pathology on the basis of haploinsufficiency or nonfunctional MLL2 protein. In accordance with its biological role, the lack of functional MLL2 protein impairs the histone methylation pathway affecting proper activation of certain genes in many organs and tissues that could result in some of the abnormalities of postnatal development of KS.
In this study, we reported the molecular characterization of an intronic c.4693+1G>A MLL2 variant in a 2-year-old Moroccan boy with KS; to the best of our knowledge, it had never been documented before. This mutation occurred de novo because it was not revealed in hematologic cells of the parents. However, a gonadal mosaicism could not be excluded. The risk for an individual family's germ cell mosaicism depends on the percentage of affected gametes in the germ cells of the parent with mosaicism; therefore, gonadal mosaicism may have important implications in genetic counseling, though familial KS recurrence by germinal mosaicism has never been reported till date.
Computational prediction confirmed by experimental evidences showed that the MLL2 identified variant leads to a premature codon stop in exon 18. It was well documented that genetic variants in disease-responsible genes that disrupt the splicing code have a key role in human hereditary disorders [Cartegni et al., 2002; Wang and Cooper, 2007] . In fact, it has been estimated that more than 60% of sequence variations are associated with splicing aberrations that should be considered as a primary mechanism of gene inactivation [López-Bigas et al., 2005] .
The predicted protein lacks the methyltransferase activity conferred by SET domain of the MLL2 protein, strongly suggesting that this variant affects the physiological function of MLL2 altering the epigenetic and transcriptional regulatory properties of the protein. This notion supports that the c.4693+1G>A splice site mutation is likely the cause of the phenotype observed in our patient. Nevertheless, leukocytes are the main source of RNA; caution should be taken when interpreting these results, since differential tissue-specific alternative splicing events could mask the real splicing outcome of a DNA variant.
Our report of the first Moroccan case with KS emphasizes that MLL2 mutations are a major cause of KS.
